Delcath Systems (DCTH) Amortization - Deferred Charges (2018 - 2019)
Delcath Systems' quarterly Amortization - Deferred Charges came in at -$1000.0 in Q4 2019, down 100.06% quarter-over-quarter from $1.7 million in Q3 2019.
Delcath Systems has reported Amortization - Deferred Charges for 2 years, with the latest figure at -$1000.0 in Q4 2019.
- For the quarter ending Q4 2019, Amortization - Deferred Charges changed N/A year-over-year to -$1000.0; the trailing twelve-month figure through Dec 2019 stood at $1.7 million (down 38.61% YoY), and the FY2019 full-year result was $1.7 million, down 39.14% from the prior year.
- Amortization - Deferred Charges for Q4 2019 stood at -$1000.0, down from $1.7 million in the prior quarter.
- The five-year high for Amortization - Deferred Charges was $2.8 million in Q2 2018, with the low at -$1000.0 in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortization - Deferred Charges (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Delcath Systems | 383.27 Mn | 293.95 Mn | 21.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -1,000.00 |
| Dec 31, 2019 | -1,000.00 |
| Sep 30, 2019 | 1.71 Mn |
| Sep 30, 2019 | 1.71 Mn |
| Jun 30, 2019 | 6,000.00 |
| Jun 30, 2019 | 6,000.00 |
| Jun 30, 2018 | 2.80 Mn |
| Jun 30, 2018 | 2.80 Mn |